Abstract
Background
The Senhance® Robotic System is a new laparoscopy-based platform that has been increasingly used in radical prostatectomy (RP) procedures. The purpose of this study is to compare the outcome of Senhance RP (SRP) with da Vinci RP (DRP) cases.
Methods
From August 2019 to April 2022, we prospectively recruited 63 cases of SRP. We compared the perioperative data, postoperative complication rates, short-term surgical outcomes (3-month postoperative undetectable prostate-specific antigen (PSA) and incontinence rates), learning curves, and cost analysis with data from 63 matched da Vinci Xi RP cases.
Results
There was no difference in BL (180 versus 180 ml, p = 0.86) and postoperative surgical complication rate (Clavient -Dindo grade I-IV, 25.3 versus 22.2%, p = 0.21) between the SRP cases and the DRP. Regarding the oncologic and continence function, there was no difference between positive margin rate (36.5% versus 41.3%, p = 0.58), rate of undetectable PSA level at postoperative 3 months (68.3 versus 66.7%, p = 0.85), and incontinence rate (14.3 versus 15.9%, p = 1.0) at postoperative 3 months between the two cohorts. The learning curve showed a quick downward slope for laparoscopic experienced surgeons. The median pocket cost for SRP patients in our hospital was $4170, which was lower than $7675 for the DRP patients.
Conclusions
Safety and short-term outcomes are comparable between SRP and DRP. For experienced LRP surgeons, using the Senhance system to perform RP is straightforward. With a more affordable price as its biggest advantage, the Senhance system may serve as a safe and effective alternative for robotic RP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Trinh QD, Sammon J, Sun M, Ravi P, Ghani KR, Bianchi M, et al. Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol. 2012;61:679–85.
Hussain A, Malik A, Halim MU, Ali AM. The use of robotics in surgery: a review. Int J Clin Pract. 2014;68:1376–82.
EAU guidelines on Prostate cancer, https://uroweb.org/guideline/prostate-cancer, 2023.
Rumolo V, Rosati A, Tropea A, Biondi A, Scambia G. Senhance robotic platform for gynecologic surgery: a review of literature. Updates Surg. 2019;71:419–27.
Kastelan Z, Hudolin T, Kulis T, Knezevic N, Penezic L, Maric M, et al. Upper urinary tract surgery and radical prostatectomy with Senhance(®) robotic system: single center experience-first 100 cases. Int J Med Robot. 2021;17:e2269.
Stephan D, Sälzer H, Willeke F. First experiences with the new Senhance® Telerobotic system in visceral surgery. Visc Med. 2018;34:31–36.
McCarus SD. Senhance robotic platform system for gynecological surgery. JSLS. 2021;25:e2020.00075.
Venckus R, Jasenas M, Telksnys T, Venckus M, Janusonis V, Dulskas A, et al. Robotic-assisted radical prostatectomy with the Senhance(®) robotic platform: single center experience. World J Urol. 2021;39:4305–10.
Samalavicius NE, Janusonis V, Siaulys R, Jasėnas M, Deduchovas O, Venckus R, et al. Robotic surgery using Senhance(®) robotic platform: single center experience with first 100 cases. J Robot Surg. 2020;14:371–6.
Kaštelan Ž, Knežević N, Hudolin T, Kuliš T, Penezić L, Goluža E, et al. Extraperitoneal radical prostatectomy with the Senhance surgical system robotic platform. Croat Med J. 2019;60:556–9.
Hudolin T, Kuliš T, Penezić L, Zekulić T, Knežević N, Čikić B, et al. Senhance robotic radical prostatectomy: A single‐Centre, 3‐Year experience. Int J Med Robot. 2023 15;e2549
Kastelan Z, Hudolin T, Kulis T, Penezic L, Gidaro S, Bakula M, et al. Extraperitoneal Radical Prostatectomy with the Senhance Robotic Platform: First 40 Cases. Eur Urol. 2020;78:932–4.
Kulis T, Hudolin T, Penezic L, Zekulic T, Saic H, Knezevic N, et al. Comparison of extraperitoneal laparoscopic and extraperitoneal Senhance radical prostatectomy. Int J Med Robot. 2022;18:e2344.
Sturch P, Raison NT, Challacombe B. Clinical utility of robot-assisted radical prostatectomy: advances and current status. Robot Surg. 2015;2:43–49.
Hagen ME, Meehan JJ, Inan I, Morel P. Visual clues act as a substitute for haptic feedback in robotic surgery. Surg Endosc. 2008;22:1505–8.
Wottawa CR, Genovese B, Nowroozi BN, Hart SD, Bisley JW, Grundfest WS, et al. Evaluating tactile feedback in robotic surgery for potential clinical application using an animal model. Surg Endosc. 2016;30:3198–209.
Taiwan Cancer Registry Database 2020, https://twcr.tw/wp-content/uploads/2023/04/CA16_LF109-v2.pdf
Greenberg SA, Cowan JE, Lonergan PE, Washington SL III, Nguyen HG, Zagoria RJ, et al. The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy. Prostate Cancer Prostatic Dis. 2022;25:344–50.
Liu J, Zhang J, Yang Z, Liu Q, Zhang W, Qing Z, et al. Comparison of Retzius-sparing and conventional robot-assisted laparoscopic radical prostatectomy regarding continence and sexual function: an updated meta-analysis. Prostate Cancer Prostatic Dis. 2022;25:47–54.
Iacovelli V, Carilli M, Sandri M, Forte V, Cipriani C, Bertolo R, et al. The role of preoperative prostatic shape in the recovery of urinary continence after robotic radical prostatectomy: a single cohort analysis. Prostate Cancer Prostatic Dis. 2023;26:374–8.
Coussons H, Feldstein J, McCarus S. Senhance surgical system in benign hysterectomy: a real-world comparative assessment of case times and instrument costs versus da Vinci robotics and laparoscopic-assisted vaginal hysterectomy procedures. Int J Med Robot. 2021;17:e2261.
Author information
Authors and Affiliations
Contributions
Concept: LHY, YCL; Provision of study material or patients: LHY, CYH, YWH, SWH; data acquisition: YCL, LHY; Data analysis and interpretation: YCL, LHY, SWH; manuscript drafting: YCL, LHY; Final approval of manuscript; SWH, CYH, CST; Language editing: TYH. All authors reviewed the paper and agreed to the published version of the manuscript
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
The study was approved by the Institutional Review Board of National Taiwan University Hospital (Approval code: 202004072RINA).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lin, YC., Yuan, LH., Tseng, CS. et al. Comparison of senhance and da vinci robotic radical prostatectomy: short-term outcomes, learning curve, and cost analysis. Prostate Cancer Prostatic Dis 27, 116–121 (2024). https://doi.org/10.1038/s41391-023-00717-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41391-023-00717-8
This article is cited by
-
Best of 2023 in Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases (2024)
-
Democratizing robotic prostatectomy: navigating from novel platforms, telesurgery, and telementoring
Prostate Cancer and Prostatic Diseases (2024)
-
hinotoriTM vs. da Vinci®: propensity score-matched analysis of surgical outcomes of robot-assisted radical prostatectomy
Journal of Robotic Surgery (2024)